In vitro cellular testing of Strontium/Calcium substituted phosphate glass discs and microspheres shows potential for bone regeneration by Patel, Uresha et al.
Received: 28 June 2018 Revised: 2 November 2018 Accepted: 9 January 2019
DOI: 10.1002/term.2796R E S E A R CH AR T I C L EIn vitro cellular testing of strontium/calcium substituted
phosphate glass discs and microspheres shows potential for
bone regenerationUresha Patel1* | Laura Macri‐Pellizzeri1,2* | Kazi M. Zakir Hossain1 |
Brigitte E. Scammell3 | David M. Grant1 | Colin A. Scotchford1 | Alex C. Hannon4 |
Andrew R. Kennedy5 | Emma R. Barney1 | Ifty Ahmed1 | Virginie Sottile21Faculty of Engineering, University of
Nottingham, Nottingham, UK
2Wolfson STEM Centre, School of Medicine,
University of Nottingham, Nottingham, UK
3Orthopaedics and Trauma Group, Division of
Rheumatology, Orthopaedics, and
Dermatology, School of Medicine, University
of Nottingham, Nottingham, UK
4 ISIS Facility, Rutherford Appleton
Laboratory, Chilton, Didcot, UK
5Faculty of Science and Technology,
Lancaster University, Lancaster, UK
Correspondence
Ifty Ahmed, Advanced Materials Research
Group, Faculty of Engineering, University of
Nottingham, Nottingham NG7 2RD, UK.
Email: ifty.ahmed@nottingham.ac.uk
Virginie Sottile, Wolfson STEM Centre,
Division of Cancer and Stem Cells, School of
Medicine, University of Nottingham, CBS
building, University Park, Nottingham NG7
2RD, UK.
Email: virginie.sottile@nottingham.ac.uk
Funding information
Science and Technology Facilities Council,
Grant/Award Number: ST/L502583/1- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of th
the original work is properly cited.
© 2019 The Authors Journal of Tissue Engineerin
*These authors contributed equally to the study a
J Tissue Eng Regen Med. 2019;1–10.Abstract
Phosphate‐based glasses (PBGs) are ideal materials for regenerative medicine
strategies because their composition, degradation rates, and ion release profiles can
easily be controlled. Strontium has previously been found to simultaneously affect
bone resorption and deposition. Therefore, by combining the inherent properties of
resorbable PBG and therapeutic activity of strontium, these glasses could be used
as a delivery device of therapeutic factors for the treatment of orthopaedic diseases
such as osteoporosis. This study shows the cytocompatibility and osteogenic potential
of PBGs where CaO is gradually replaced by SrO in the near invert glass system
40P2O5·(16‐x)CaO·20Na2O·24MgO·xSrO (x = 0, 4, 8, 12, and 16 mol%). Direct
seeding of MG63 cells onto glass discs showed no significant difference in cell
metabolic activity and DNA amount measurement across the different formulations
studied. Cell attachment and spreading was confirmed via scanning electron
microscopy (SEM) imaging at Days 3 and 14. Alkaline phosphatase (ALP) activity
was similarly maintained across the glass compositions. Follow‐on studies explored
the effect of each glass composition in microsphere conformation (size: 63‐125 μm)
on human mesenchymal stem cells (hMSCs) in 3D cultures, and analysis of cell
metabolic activity and ALP activity showed no significant differences at Day 14 over
the compositional range investigated, in line with the observations from MG63 cell
culture studies. Environmental SEM and live cell imaging at Day 14 of hMSCs seeded
on the microspheres showed cell attachment and colonisation of the microsphere
surfaces, confirming these formulations as promising candidates for regenerative
medicine strategies addressing compromised musculoskeletal/orthopaedic diseases.
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2 PATEL ET AL.1 | INTRODUCTION
Phosphate‐based glasses (PBGs) are highly suited biomaterials to
deliver therapeutic ions, particularly for bone regeneration, because
their main constituents (i.e., calcium, phosphate, sodium, and
magnesium) are found to occur in the inorganic phase of natural bone
(Jones & Clare, 2012). The ability to control their dissolution rates, and
thus the release of ions, serves as a highly attractive route to direct
the biological response for the repair and regeneration of both hard
and soft tissues (Hoppe, Guldal, & Boccaccini, 2011). Furthermore,
the geometry of PBG can be varied by means of fibre
drawing (Ahmed, Collins, Lewis, Olsen, & Knowles, 2004; Sharmin,
Rudd, Parsons, & Ahmed, 2016), scaffold production (Jones et al.,
2010), and microsphere manufacture (Jones et al., 2010; Lakhkar
et al., 2012), making them an extremely versatile and tuneable
material.
A particular ion of interest is strontium (Sr), especially for use in
hard‐tissue repair applications; it has been investigated for incorpora-
tion and/or substitution into a vast array of materials such as organic
polymers, ceramics, glasses, composites, and alloys (Han et al., 2016;
Liu, Li, Ji, & Jia, 2013; Mushahary et al., 2016; Park, Kang, & Hanawa,
2016; Ray et al., 2016; Schumacher & Gelinsky, 2015; Wu, Lin, Yang,
& Lee, 2015). Strontium is also of clinical importance because it
has been shown to promote bone formation via stimulation of
pre‐osteoblastic cells replication and to reduce bone resorption via
inhibition of osteoclast formation and activity (Canalis, Hott, Deloffre,
Tsouderos, & Marie, 1996). In the past, strontium ranelate was
administrated to osteoporotic patients, due to its anabolic activity
and antiresorptive effect on bone tissue (Ammann, 2005), as the
imbalance of bone deposition and resorption characterises osteoporo-
sis (Blake & Fogelman, 2006). However, since 2013, the European
Medicine Agency has restricted the use of strontium ranelate for the
treatment of severe osteoporosis in postmenopausal women and adult
men at high risk of fracture due to increased cardiovascular risks
(National Institute for Health and Care Excellence (NICE), 2011).
Therefore, investigation into alternative administration routes such
as controlled and localised delivery of the ion, as opposed to systemic
delivery, could be very beneficial.
Substitution of calcium for strontium in biomaterials (e.g., ortho-
paedic cements and bioactive glasses) has been of interest as both
play a similar chemical role because they are divalent cations with a
comparable ionic size (Ca2+ 1.00 Å and Sr2+ 1.18 Å) and are accumu-
lated in bone. Due to the ease of substitution of these two cations
within a glass system, as well as the positive influence strontium canTABLE 1 Compositional information, glass transition temperature, and g
Glass code P2O5 (mol%) CaO (mol%) Na2O (m
P40 40 16 20
Sr4 40 12 20
Sr8 40 8 20
Sr12 40 4 20
Sr16 40 — 20have on bone metabolism, the use of this ion for bone tissue
engineering and regenerative medicine strategies constitutes an area
of growing interest (Abou Neel et al., 2009; Al Qaysi et al., 2015;
Lee, Obata, Brauer, & Kasuga, 2015). Several studies have investigated
the behaviour of cells such as osteoblast‐like cells and mesenchymal
stem cells towards strontium‐containing biomaterials (Aina et al.,
2013; Lin et al., 2013; Ni, Shu, Huang, Lu, & Pan, 2012; Santocildes‐
Romero et al., 2015). For instance, Sr‐substituted hydroxyapatite
nanocrystals were shown to dose dependently promote higher levels
of alkaline phosphatase (ALP) activity, collagen type‐I, and osteocalcin
production in comparison with pure hydroxyapatite in the osteoblast‐
like MG63 cell line (Capuccini et al., 2009). Investigation into the
effects of Sr‐containing PBG has also been reported; for example,
human osteosarcoma cells showed higher degree of adhesion to
PBG with 1 and 3 mol% SrO substitution in comparison with the 5%
and SrO‐free control (Abou Neel et al., 2009).
The aim of this study was to investigate the cytocompatibility of
near invert phosphate glasses where calcium was eventually fully
substituted for strontium on a gradual basis in a previously reported
glass system 40P2O5·(16‐x)CaO·20Na2O·24MgO·xSrO (x = 0, 4, 8,
12, and 16 mol%; Patel et al., 2017). All formulations were
manufactured as discs and microspheres and tested for their ability
to support adhesion, proliferation, and osteogenic differentiation using
human osteoblast‐like MG63 cells and human mesenchymal stem cells
(hMSCs), respectively, in order to investigate their potential use for
bone repair applications via two clinically relevant cell types.2 | MATERIALS AND METHODS
2.1 | PBG sample production
The following precursors were used to fabricate glass rods of
the compositions shown in Table 1: P2O5, NaH2PO4, CaHPO4,
MgHPO4·3H2O, and SrCO3 (Sigma Aldrich, UK). The weighed
precursors were thoroughly mixed and then heated in a 5% Au/95%
Pt crucible at 350°C for 30 min to dehydrate and remove CO2 before
placing the crucible into a furnace heated to 1150°C for 90 min. The
melts were poured into preheated graphite moulds (10°C) above Tg
of each sample and annealed for 1 hr, followed by slow cooling to
room temperature overnight. Each rod was then cut into discs of
9 mm × 2 mm using a diamond saw using methanol as a lubricant
agent. Sterilisation of the discs was carried out via UV light exposure
for 1 hr on either side.lass code of each formulation
ol%) MgO (mol%) SrO (mol%) Tg (±1°C)
24 — 450
24 4 447
24 8 447
24 12 447
24 16 443
PATEL ET AL. 32.2 | Glass microsphere production
The quenched glass samples were ground using a planetary zirconia ball
mill (Retsch Planetary Mill PM100), operated for 2 min at 500 rpm.
Glass powder was separated into particle size in the range
63–125 μm using stainless steel sieves (VWR International, UK). The
ground particles were fed through a flame spheroidisation apparatus
consisting of (a) a powder feeder, (b) an oxy/acetylene thermal spray
gun (MK74 Thermal Spray gun Metallisation Ltd., UK), and (c) a series
of collection vessels. Microspheres were collected from the collection
vessel furthest away from the spray gun. Microspheres of all composi-
tions were sterilised bywashing twice in 70% EtOH for 15min followed
by complete evaporation at room temperature in a sterile environment.2.3 | Cell culture
For cell experiments, materials were purchased from ThermoFisher
Scientific (UK) unless otherwise stated.
The osteoblast‐like cell line MG63 (obtained from European col-
lection of cell cultures ‐ ECACC) was seeded on each disc at a density
of 4 × 104 cells/cm2 and cultured using Dulbecco's Modified Eagle
Media supplemented with 10% fetal calf serum, 2% HEPES Buffer,
2% antibiotics–antimycotic agents, 1% L‐glutamine, 1% non‐essential
amino acids and 0.85 mM of ascorbic acid (Sigma Aldrich, UK) at
37°C and 5% CO2 in a 48‐well plate. Tissue culture plastic (TCP)
was employed as control of conventional culture method.
For the experiments with the PBG microspheres, 2 × 104 GFP‐
labelled hMSCs (Harrison et al., 2017) were seeded onto 10‐mg sterile
microspheres in low‐adherent 48‐well plate previously coated with 1%
w/v solution of poly(2‐hydroxyethyl methacrylate) (poly‐HEMA, Sigma
Aldrich) and ethanol 95%. Cells were cultured during 14 days at 37°C
and 5% CO2 in standard cell (SC) culture medium (low glucose
Dulbecco's Modified Eagle Media supplemented with 10% fetal calf
serum, 1% penicillin and streptomycin, 1% L‐glutamine, and 1% of
non‐essential amino acids). For both cell types, medium was refreshed
every 48 hr.2.4 | Cell metabolic activity
Cell metabolic activity of MG63 cells cultured on PBG discs and TCP
was evaluated at Days 1, 3, 7, and 14 using Alamar Blue assay. Briefly,
1 ml of Alamar Blue solution (1:9 Alamar blue:Hanks Balanced Salt
Solution) was added to each well and incubated for 90 min at 37°C
and 5% CO2 followed by further 10 min on a shaker at 150 rpm. For
each disc, three aliquots of 100 μl were transferred to a 96‐well plate.
FLx800 fluorescence microplate reader (BioTek Instruments Inc.) was
used to measure fluorescence at 530‐nm excitation and 590‐nm
emission wavelengths.
Cell metabolic activity of hMSCs was assayed using Presto Blue
reagent at Days 2, 7, and 14 after seeding onto the microspheres
according to the manufacturer's instructions. Briefly, a solution of SC
medium supplemented with 10% of Presto Blue reagent was prepared,and 300 μl was added to the cells for 40 min at 37°C and 5% CO2.
After the incubation, 250 μl of the solution was transferred to a clear
bottom 96‐well plate; fluorescence measurement was performed in
the microplate reader Infinite 200 (Tecan, CH) setting 560 nm and
590 nm as excitation and emission wavelengths, respectively.2.5 | Evaluation of DNA content
DNA content was evaluated in MG63 cells at Days 1, 3, 7, and 14 of
culture on PBG discs and TCP control. Briefly, samples were washed
three times with warm (37°C) PBS and immersed in 1 ml of deionised
water. Samples were frozen‐thawed three times to lyse the cells and
release nuclear content. Lysed samples were then thoroughly mixed
using a vortex for 30–60 s, and 100 μl of each sample was aliquoted
into a 96‐well plate. Hoechst 33258 stain solution was prepared by
dissolving 1 mg of bisbenzimide stain in 1 ml of distilled water and
diluted 1:50 in TNE buffer (10 mM Tris, 2 M NaCl, and 1 mM EDTA
in deionised water, adjusted to pH 7.4); DNA standard curve was
prepared using calf thymus DNA (Sigma, UK) diluted in TNE buffer.
Each well was then topped with 100 μl of Hoechst 33258 stain and
agitated using a plate shaker. Fluorescence was measured at 360 nm
and 460 nm as excitation and emission wavelengths using FLx800
microplate fluorimeter (BioTek Instruments), respectively.2.6 | ALP activity
The Granutest 25 ALP assay (Randox, UK) was used to measure ALP
activity in MG63 cells. Three aliquots of 50 μl of cell lysate (as prepared
for DNA quantification assay in Section 3.4) were transferred to a
96‐well plate and topped with 50 μl of ALP substrate (p‐nitrophenyl
phosphate 10 mM in diethanolamine buffer 1 mM at pH 9.8, with
MgCl2 0.5 mM). Plates were shaken gently for 5 min on a plate shaker,
and absorbance was measured at wavelength of 405 nm using an
FLx800 microplate colorimeter (BioTek Instruments).
ALP activity of hMSCs was assayed at Day 14 after seeding on the
PBG microspheres. Briefly, live cells were washed twice with PBS and
incubatedwith 300 μl of a solution of 1mg/ml p‐nitrophenyl phosphate
and 0.2 M Tris buffer (SIGMAFAST, Sigma‐Aldrich) prepared according
to the manufacturer's instructions. ALP activity was monitored in the
microplate reader (Tecan, CH) analysing the optical density at 405 nm
performing 12 readings over 24 min. ALP solution was subsequently
replaced with fresh SC medium, and cells returned to the incubator.2.7 | Cell imaging
At Days 3 and 14, MG63 cells seeded on PBG discs were washed
three times with warm (37°C) PBS and fixed with 3% glutaraldehyde
in 0.1 M sodium cacodlyated buffer for 30 min. Fixative was then
replaced with 7% sucrose solution for 30 min. Specimens were again
washed three times with 0.1 M cacodylate buffer for 5 min. Each sam-
ple was then coated with 1% osmium tetroxide in PBS for 45 min. This
was followed by a dehydration process by incubating the samples in a
4 PATEL ET AL.graded ethanol series (20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%,
and 100% ethanol) for 5 min in each concentration and dehydrating
the samples in 100% ethanol for a second time for 5 min. Samples
were dried via hexamethyldisilazane, mounted onto a carbon scanning
electron microscopy (SEM) stub and sputter‐coated with ~15 nm of
platinum. Cells were visualised using a Philips XL30 scanning electron
microscope operated at 10 kV.
Fluorescence live cell imaging of hMSCs seeded on the PBG
microspheres was performed at Days 1 and 14 using a Juli FL Stage
system and a Leica DM IRB microscope connected with a QICAM Fast
1394 camera, respectively. For environmental SEM (ESEM), hMSCs
were fixed at Day 14 through a 10‐min incubation with 4% parafor-
maldehyde, washed twice with distilled water, and analysed using a
FEI Quanta 650 ESEM microscope.
2.8 | Statistical analysis
Three independent experiments were performed, and results are
shown as mean ± standard error of mean. Statistical analysis was
performed using Prism software package (version 7.01, GraphPad
Software, San Diego, CA, www.graphpad.com). Two‐way analysis of
variance was calculated followed by a Tukey's multiple comparison
test. The mean difference was considered to be significant at 0.05
and 95% confidence interval.3 | RESULTS
3.1 | Evaluation of MG63 cell growth on disc PBG
formulations
In order to determine the cytocompatibility of glass samples with
varying SrO content, the osteoblast‐like MG63 cell line was seededFIGURE 1 Quantification of metabolic activity (a) and DNA amount (b) in
discs with varying Sr mol% and TCP. a.f.u.: arbitrary fluorescence units; TC
n = 15. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, # p = 0.0594onto the surface of glass discs, and the cell metabolic activity as well
as DNA quantity was analysed at Days 1, 3, 7, and 14. Metabolic
activity analysed using the Alamar Blue assay showed an increase in
cell response for all compositions from Day 3, whereas no significant
differences were detected between formulations at all the time points
considered (p > 0.9). At Days 3 and 7, significantly greater values were
observed for the TCP control in comparison with all glasses, whereas
at Day 14, this difference was maintained only in comparison with
P40, Sr4, and Sr8 (see Figure 1a).
Moreover, the quantification of total cell DNA amount showed a
significant increase at each time point up to Day 7 (D1 vs. D3:
p < 0.01; D7 vs. D3: p < 0.0001), followed by a plateau at Day 14. It
is worth noting that no significant differences were observed between
all formulations and the TCP control at each time point (p > 0.9; see
Figure 1b).3.2 | Evaluation of hMSC cell growth on microsphere
PBG formulations
The metabolic activity of hMSCs cultured on microspheres
manufactured from each PBG composition was assayed at Days 2, 7,
and 14 after seeding. The results showed a significant increase in cell
response over time (p < 0.0001), whereas no differences between cell
cultures on the different PBG compositions were detected at each
time point (p > 0.90; see Figure 2).3.3 | ALP activity
ALP activity was measured as an early marker of osteogenic
differentiation in MG63 and hMSCs after 14 days of culture on both
PBG discs and microspheres, respectively.MG63 after 1, 3, 7, and 14 days of culture on phosphate‐based glass
P: tissue culture plate. Error bars represent standard error of mean;
FIGURE 2 Quantification of metabolic
activity in human mesenchymal stem cells at
Days 2, 7, and 14 of culture onto phosphate‐
based glass microspheres containing varying
Sr mol%. a.f.u.: arbitrary fluorescence units;
TCP: tissue culture plate. Error bars represent
standard error of mean, n = 12. ***p < 0.001,
****p < 0.0001
PATEL ET AL. 5MG63 cells cultured on discs showed no significant difference in
ALP activity across all the formulations tested in comparison with
the TCP control (p > 0.8; see Figure 3a).
ALP activity in hMSCs cultured on PBG microspheres was
evaluated at Day 14, and this analysis also showed no significant
difference between all compositions (p > 0.2; see Figure 3b), in line
with the results obtained for MG63 cells.3.4 | MG63 cell imaging on discs
MG63 cells cultured on PBG discs were visualised via SEM at Days 3
and 14 (Figure 4). Cells were seen to have attached and spread by Day
3, and a confluent layer across all sample compositions was observedFIGURE 3 Alkaline phosphatase (ALP) activity measured at Day 14 in (a)
plastic (TCP) and (b) human mesenchymal stem cells cultured on phosphate
density (O.D.). Error bars represent standard error of mean; n = 12at Day 14. Cells appeared to be spindle‐like with lamellipodia and
filopodia extending to neighbouring cells in all glass formulations
studied.3.5 | hMSC cell imaging on microspheres
Live fluorescence images of hMSCs showed a similar level of cell
adhesion to PBG microspheres across all formulations at Day 1,
whereas the presence of cell–microsphere aggregates was observed
at Day 14 (see Figure 5a). These aggregates were further analysed
via ESEM imaging, which showed the attachment and spreading of
cells on the microsphere surface, as well as the presence of a dense
cell‐derived matrix surrounding the microspheres (see Figure 5b).MG63 cells cultured on phosphate‐based glass discs and tissue culture
‐based glass microspheres. Graphs show arbitrary units (a.u.) of optical
FIGURE 4 Representative scanning electron
microscopy images of MG63 cell cultures on
all compositions investigated of phosphate‐
based glass discs at 3 and 14 days. Scale
bar = 20 μm
6 PATEL ET AL.4 | DISCUSSION
This study aimed to assess the biological properties of a series of near
invert PBGs where CaO content was gradually substituted for SrO by
0% to 100% (Patel et al., 2017) and manufactured in disc and micro-
sphere forms. Microspheres in particular provide the advantage of uni-
formity in size and shape, making delivery to the target tissue possible
through simple injection procedures (Kim & Pack, 2006). Spherical
material morphologies also enable enhanced versatility for filling even
complex defect shapes compared with bulk scaffolds, which tend to
have predetermined shapes (Choi, Zhang, Yeh, Wooten, & Xia,
2012). The increased surface area also allows for efficient cell attach-
ment and spreading, whereas the microsphere interparticulate gapswould be beneficial for oxygen and nutrient flow (Cai, Chen, Hong,
Liu, & Yuan, 2013). MG63 cells have been widely used as a versatile
tool for the evaluation of the osteogenic potential of new materials
and compounds (Rodriguez, Saxena, Hixon, Sell, & Bowlin, 2016),
whereas hMSCs cells have been included in this study as a clinically
relevant cell model, largely used in in vitro and in vivo studies of bone
regeneration (Knight & Hankenson, 2013).
As previously demonstrated, the gradual replacement of CaO con-
tent for SrO by 0% to 100% in the glass system used in the this study
(40P2O5·(16‐x)CaO·20Na2O·24MgO·xSrO, where x was 0, 4, 8, 12,
and 16 mol%) did not significantly alter the PBG dissolution rate, pro-
viding a means of controlled release of therapeutic ions such as stron-
tium, magnesium, phosphate, and calcium (Patel et al., 2017). The
FIGURE 5 Representative images of human mesenchymal stem cells seeded on phosphate‐based glass microspheres through (a) live cell
fluorescence imaging and (b) environmental scanning electron microscopy. Scale bar: a = 250 μm; b = 100 and 50 μm [Colour figure can be
viewed at wileyonlinelibrary.com]
PATEL ET AL. 7evaluation of cytocompatibility performed in this study showed that
all PBG formulations, manufactured as discs or microspheres,
supported cell adhesion and growth up to 14 days with no major
differences observed between the formulations investigated. Also, in
the case of MG63 cells, the cell response was lower than the TCP
control, whereas these differences were not observed from the
DNA quantification analyses. However, in the literature, contrasting
data are available. The incorporation of 5 and 10 at% of SrO into
hydroxyapatite‐induced similar levels of proliferation of MG63 cells
than theTCP at Days 14 and 21 (Boanini et al., 2014). On the contrary,
all formulations of an invert glass system with 0 to 100 mol% of SrO
substitution for CaO (30P2O5·(60‐x)CaO·7MgO·3TiO2·xSrO (where
x = 0, 17, 33, 50, 67, 83 and 100 mol%) induced a significant increase
in cell number of MC3T3‐E1 cells in comparison with TCP control at
Days 3 and 5 (Lee et al., 2015). Interestingly, the Bioglass series
46.46SiO2·1.07P2O5·26.38Na2O·23.08CaO with 0, 10, 50, and
100 mol% of CaO substitution for SrO significantly induced the
metabolic activity of Saos‐2 cells in comparison with the SrO‐free
formulation (Gentleman et al., 2010). A dose‐specific induction of
proliferation was reported for MG63 cells grown on PBG containing
1 mol% SrO in comparison with 3 and 5 mol% and the SrO‐free
samples (Abou Neel et al., 2009; N. Lakhkar, Abou Neel, Salih, &
Knowles, 2011). All these data suggest that the substitution of CaO
for SrO is cytocompatible in a wide range of glass formulations
including those selected in this study.The SEM and fluorescence image micrographs obtained in this
study complemented the cell metabolic activity showing cell adhesion
to the glass surface and spreading from early time points for both cell
types, with no obvious difference in cell morphology with varying
concentrations of SrO in the PBG formulations investigated. The
influence of glass composition and degradation rate on cell behaviour
was discussed by Skelton et al. (2007) who demonstrated the lack of
attachment, proliferation, and increased cell death for human bone
marrow stromal cells and human fetal osteoblasts cultured on ternary
PBG systems. Such detrimental effects on cell behaviour were
attributed to an unstable PBG surface in contact to cell culture
medium, which led to a rapid dissolution of these fast degrading
ternary formulations preventing cells from adhering to the surface.
In vivo too, the degradation rate of a material can significantly
affect the outcome of the therapeutic strategy by either altering
the structural support provided to the endogenous tissue and/or
stimulating the inflammatory response (Vishwakarma et al., 2016;
Yu, Tang, Gohil, & Laurencin, 2015).
The dissolution behaviour of the PBG formulations studied here
has been previously reported, showing a more stable PBG surface
with the addition of SrO, with a weight loss ranging between 0.2%
and 0.13% in 30 days for the discs (Patel et al., 2017). Evidence
also suggests that the degradation rate of the glass increases with
spherical geometries (Hossain et al., 2018; Islam, Hossain, Sharmin,
Parsons, & Ahmed, 2017); however, in vivo studies would need to
8 PATEL ET AL.be conducted to establish how this could affect the regenerative
potential of the material.
The ability of a biomaterial to induce osteogenic differentiation is a
desirable property in view of the application for bone repair. In this
study, the assay of ALP activity was performed as an early marker of
osteogenic commitment. This enzyme is constitutively active at low
levels in all the cells, but its activity significantly increases during the
early stages of osteogenic differentiation; therefore, it is commonly
considered a good marker for the detection of early osteogenic differ-
entiation (Golub & Boesze‐Battaglia, 2007; Prins et al., 2014; Stein,
Lian, & Owen, 1990). Strontium ranelate, an Sr‐based drug previously
administrated to osteoporotic patients, has been reported to have a
dual role by enhancing differentiation of osteogenic progenitor cells
as well as by inhibiting osteoclastogenesis (Brennan et al., 2009;
Fonseca & Brandi, 2010). In this study, no significant difference in
ALP activity was observed between all the formulations including the
TCP control with either cell types. In the literature, different PBG
systems containing a wide range of SrO mol% have been reported to
promote ALP activity. For instance, Lee et al. (2015) found a dose‐
dependent response in the induction of ALP at Day 10 using mouse
MC3T3 cells cultured on the invert glass system 30P2O5·(60‐x)
CaO·7MgO·3TiO2·xSrO (where x = 0, 17, 33, 50, 67, 83, and
100 mol%). Also, higher ALP activity of MG63 cells was observed at
Day 14 of culture on PBG glass discs with 17.5 mol% of SrO (Al Qaysi
et al., 2015). Incorporation of 5 and 10 at% of SrO into other biomate-
rials such as hydroxyapatite resulted in significant increase of ALP
activity compared with the TCP control in a dose‐dependent manner
(Boanini et al., 2014). It seems that such osteogenic effect exerted by
strontium may be mediated by the activation of the Wnt/β‐catenin
pathway both in vitro and in vivo (Yang et al., 2011), by stimulating
the activity of the ALP enzyme as well as the production of ECM com-
ponents including collagen type‐I and osteopontin. It is conceivable
that the observed response may be the result of a combination of
factors rather than the sole exposure to strontium including the
combination and rate of ions simultaneously released during glass
degradation, which have all been described to influence cell behaviour
(Maeno et al., 2005).
Overall, the findings of this study complemented previous works,
which aimed to characterise the effect of gradually substituting CaO
for SrO in a PBG system. More interestingly, our group has recently
reported the manufacturing of PBG microspheres in highly porous
conformation with larger surface area and increased degradation rate
(Hossain et al., 2018). These microspheres have also shown the ability
to encapsulate stem cells and will be further investigated for promot-
ing cell growth and pore colonisation, to deliver enhanced advantages
for bone tissue growth via a biomimetic environment. Future work will
also be aiming to manufacture novel formulation of porous PBG
including therapeutic ions such as strontium with the aim to provide
new insights for the design of novel materials for minimally invasive
orthopaedic repair and regeneration applications. A comprehensive
evaluation of the biological potential of these formulations in vitro
would provide important additional information for the further
progression toward in vivo studies. In particular, in view of theanti‐resorptive activity attributed to strontium as well as the impor-
tance of appropriate vascularisation to support the new tissue, further
studies could evaluate how these glass formulations can affect the
activity of osteoclast cells and the formation of vessel‐like structures
by endothelial cells.5 | CONCLUSIONS
This study showed that discs and microspheres manufactured from
the near invert glass system 40P2O5·(16‐x)CaO·20Na2O·24MgO·xSrO
(x = 0, 4, 8, 12, and 16 mol%) are cytocompatible and promoted adhe-
sion and growth of human MG63 and hMSCs, respectively, up to
14 days. The observations made in this study suggest that these mate-
rials are appropriate for the culture, expansion, and cellular activity of
human cells constituting as excellent candidates for bone
regeneration.
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